Surmasis Pharmaceutical

Surmasis Pharmaceutical (United States) has no DMF, CEP or site registration linked in our records. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Surmasis Pharmaceutical: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/surmasis-pharmaceutical

Overview

Surmasis Pharmaceutical is a pharmaceutical company headquartered in West Des Moines, United States.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832025-08-01

    Procedures not in writing, fully followed

  • 4832025-08-01

    No written record of investigation

  • warning_letter2018-11-06

    FDA Warning Letter (drug product)

For suppliers

Is this Surmasis Pharmaceutical?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.